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Bipolar disorders are a group of illnesses in which pharmacologic treatment is not enough 
to control symptoms and to keep up psycossocial functio ing. Associated interventions are 
supposed to increase the effectiveness, including psychotherapies and psychoeducational 
methods. Among them, family interventions deserve att ntion on account of the burden of 
illness for relatives and caregivers and the possibility of their cooperation in relieving 
patients' distress.  
Objectives 
The objectives of this review are to investigate th effectiveness of family interventions in 
the treatment of bipolar disorders through assessments of all randomised controlled trials 
comparing them to: other type of family interventio, psychoeducation, psychotherapy, or 
no psychossocial intervention.  
Search strategy 
Eletronic search of COCHRANE CONTROLLED TRIALS REGISTER (2006-3), 
MEDLINE (2006), EMBASE (2006) and LILACS (2006), reference searching of included 
studies, and personal communication.  
Selection criteria 
This review includes: randomised trials; participants with bipolar disorder and their 
relatives or caregivers; family psychossocial interventions of any type; primary outcomes 
are changes in the status of symptoms and relapse rtes.  
 
Data collection & analysis 
Data independently extracted by 2 authors. Risk Ratio and weighted mean difference were 
estimated for included studies outcomes.  
Main results 
Seven trials included. All of them assess psychoeducational methods and only one assesses 
a type of psychotherapy in one of its three arms. It was not possible to perform meta-
analysis in primary outcomes. It was possible to perform one meta-analysis for dropouts, a 
secondary outcome, and also the estimation of NNT for relapse prevention in one study.  
Reviewers' conclusions 
Until now there is no available high quality evidenc  enough to support the clinical use of 
family interventions in order to increase outcomes in the treatment of bipolar disorders. 
Researchers should enroll themselves in production of randomised controlled trials with 
rigorous methodology.  
Background 
Bipolar disorders are a group of illnesses characteised by the presence of symptoms of 
pathologic variations of mood. According DSM-IV-TR patients suffering from bipolar 
disorder type I have at least one episode of mania or mixed, commonly presenting more 
than one, and also depressive episodes; in bipolar diso der type II there is at least one 
episode of depression and one or more episodes of hyp mania (never one episode of mania, 
associated); patients may also exhibit mood symptoms but don't meet criteria for bipolar 
disorder I or II, leading to a diagnosis of bipolar disorder not otherwise specified; 
cyclothymic disorder may be diagnosed in patients who don't meet criteria for manic, 
mixed, or major depressive episode but exhibit periods of depressive symptoms and periods 
of hypomaniac symptoms for at least 2 years (adults) and no symptom-free period longer 
than 2 months. Although it has been usually described as a periodic disease, important 
subthreshold mood liability may occur between episode  and become an important cause of 
impairment in general abilities and potential harmful changes in life of the affected people( 
Kalbag 1999, Gitlin 1995). Consequently it has been associated with significant morbidity, 
psychosocial and laborative maladjustment and high suicide risk.  
Lifetime prevalence of bipolar disorder I ranges from 0.4% to 1.6%, for bipolar disorder II 
it is 0,5% and the range for cyclothymia is between 0.4% and 1.0%, for the adult 
population; different ethnic groups do not show differences for these rates; bipolar I 
disorder affects the same proportion of men and women, but bipolar II disorder is more 
common in women; when the first episode is manic it is more likely to occur in men than in 
women, but for both the first episode is more frequently a depressive one; divorce rates are 
two or three times higher among subjects with bipolar disorder than in general population 
and occupational status is twice as likely to deteriorate (APA 2002). It is estimated that 
25% to 50% of all people suffering from bipolar disorder will make a suicide attempt in 
their lives (Jamison 2000).  
 
Bipolar and unipolar mood disorders might be distinct entities (Goodwin 1990), though this 
concept is not consensual. The diagnosis presently is made mostly according to ICD-10 and 
DSM-IV-TR. The concept of bipolar disorder has been broadened and this illness identified 
more often (Akiskal 2006). Etiology seems to be strongly associated to genetic and other 
biologic factors but the involvement of psychosocial factors are increasingly gaining 
attention (Alloy 2005).  
Prognosis for bipolar disorder, in spite of continual maintenance pharmacological 
treatment, is not always favourable and there is evidence suggesting that the course is less 
benign than thought before. One study demonstrated 73% of relapse risk during a period of 
5 years post recovery of an episode and that morbidity appeared to be a more sensitive 
correlate of psychosocial functioning than was the number of relapses (Gitlin 1995). 
Psychosocial impairments may persist even when mood symptoms are controlled by 
medications (Zaretsky 2003). The treatment has been predominantly with pharmacological 
agents such as mood stabilizers, antidepressants and antipsychotics when necessary, 
sometimes benzodiazepines and more rarely electroconvulsive therapy. Compliance is often 
an important problem with these patients.  
Biological treatments are the fundamental tool in managing the illness, however they are 
not enough to control all the problems associated with the course of disorder and its 
consequences in patient's life condition (Hilty 1999). It is especially difficult to have a 
satisfactory prevention of relapses exclusively with the available medications (Gitlin 1995, 
Gelemberg 1989). In addition, sophistication and complexity of the questions linked to 
human psychological functioning and social performance demand more specific 
interventions in order to address subtle aspects of the ill person. It is also important to 
remember that subsyndromal symptoms remaining after the acute episode may be very 
difficult to manage, even with appropriated pharmacological treatment (Coryell 1993), and 
might cause non-compliance and impair rescuing the former capacities and wellness.  
Psychosocial interventions have been used for bipolar disorder since the pre-
pharmacological treatment era. Most times they failed in the early times, probably due to no 
concomitant medications use. Nowadays the course of bip lar disorder has changed with 
the use of suitable biological treatment, and several fo ms of psychotherapies and 
psychoeducational methods have been applied as adjunctive care, apparently with more 
success (Huxley 2000; Gonzales-Pinto 2004; Jones 2004). Different types of individual, 
group, and family psychosocial interventions have be n applied, in fact, with a non-specific 
or a specially suited design for bipolar disorder (Jones 2004). Cognitive-behavioral therapy, 
interpersonal therapy, interpersonal and social rhythm therapy, psychoanalytical based 
psychotherapy, family therapies (based on different theoretical orientations as cognitive-
behavioral, psychoanalytical and systemic theories) (Mikolwitz 1990;Huxley 2000; 
Reinares 2002; Fristad 2003; Jones 2004) and several types of group therapies are examples 
of psychotherapies that can be used to treat bipolar atients. Psychoeducational methods 
may be also of different formats, in individual, group of patients or family settings.  
It is almost consensual that bipolar disorder affects the relationships in families of patients 
and also the family relationships and behaviors affect the course of bipolar disorder. Family 
interventions seem to be useful for the control of the illness (Reinares 2002). Under the 
name of family therapy one can find very different ki ds of interventions with diverse 
concepts as foundations. They can operate as direct psy hoeducational methods with 
 
explicit objective of instructing patients and relatives or carers about vicissitudes of the 
illness, or can be cognitive-behavioral therapy models with more or less educational 
purposes and often communication enhancement and problem solving training, or they yet 
can signify efforts for modifications in the functioning of all the family group, treating 
them as a system where none is isolated and none is th single owner of the illness, it is the 
case of systemic family therapy models; just to mention some possibilities.  
The aim of this review is to collect and summarise all relevant trials that evaluate the 
effectiveness of all possible different forms of family therapies in those several types of 
theoretical basis, for bipolar disorder. Family therapy will be understood here as any type of 
psychosocial interventions for family members of bipolar patients, with or without the 
participation of the individual with bipolar disorder as family psychoeducation, cognitive-
behavioral family therapy, cognitive family therapy, behavioral family therapy, 
interpersonal family therapy, systemic family therapy, psychodynamic family therapy, 
couples therapy (psychoeducational, cognitive-behavior l, cognitive, behavioral, systemic 
or psychodynamic). It will be also included therapies with groups of couples or families.  
Objectives 
i) To investigate the effectiveness (improvement of symptoms or reduction of relapse rates) 
of family therapies for bipolar disorder as compared to:  
· no psychosocial intervention  
· other psychosocial intervention  
ii) Where possible to perform a meta-analysis of the studies  
Criteria for considering studies for this review 
Types of studies 
All relevant randomised controlled trials (RCTs) evaluating family therapies for bipolar 
disorder. Some specific relevant outcome data from quasi-randomised studies could be 
considered. Cluster randomised trials would also be considered. For cross-over studies, 
only the first arm of the trial would be analysed, considering the potential contamination 
after the cross-over procedure.  
Types of participants 
People with a diagnosis of bipolar disorder based on DSM-III, DSM-III-R, DSM-IV, DSM-
IV-TR, IDC 9 or ICD 10 criteria and their relatives or caregivers. There were no 
restrictions regarding gender, age, ethnical group, nationality, stage of the disease (remitted 
or in acute phase), presence of co-morbidity, and use of concomitant medication (since 
both, experimental and comparison groups, are under the similar regimen).  
 
Types of interventions 
Family therapy, used for treating bipolar disorder in acute phase, or as preventive 
intervention in stable subjects. Family therapy may include any type of psychosocial 
intervention for families of bipolar patients (couples or group of relatives of a bipolar 
patient, or group of families of different bipolar patients, with or without the attendance of 
the bipolar patient) in its diverse types of theoretical foundations. The types of family 
intervention can be: family psychoeducation, cognitive-behavioral family therapy, 
cognitive family therapy, behavioral family therapy, interpersonal family therapy, 
psychodynamic family therapy, systemic family therapy, a mixed modality between this 
types (e.g. an intervention mixing psychoeducational a d cognitive-behavioral techniques), 
and it was included couples therapy and therapies wth groups of families. They may be 
administered by psychiatrists, psychologists or other professionals properly prepared.  
Types of outcome measures 
Primary outcome: effectiveness of interventions as measured by:  
· Changes in the status of the illness, as measured by standard scales, such as Young Mania 
Rating Scale-YMRS, Montgomery Affective Disorders Rating Scale-MADRS, Hamilton 
Rating Scale for Depression-HRSD, Schedule for Affectiv  Disorders and Schizophrenia-
SADS, Brief Psychiatric Rating Scale-BPRS, Bech-Raphaelson Manic Scale, or any other 
validated scale; for studies where subjects are in the acute phase of disease or have sub 
syndromic symptoms in maintenance phase;  
· Relapse rates, for studies where subjects are stable (not in an acute phase of disease).  
Secondary outcomes:  
· Hospitalisation;  
· Length of remission;  
· Suicide attempts  
· Treatment compliance (attendance to psychosocial tre tment appointments)  
· Dropout rates  
· Number of subjects who dropped out because of lack of efficacy or for feelings of 
worsening  
· Other outcomes:  
a) Employment related events (Work Adjustment Scale, and any other validated scale or 
objective event like as loose of job, interruption or return to work)  
b) Social and family functioning (UCLA-Social Attainment Survey, Family Assessment 
Device-FAD, Global Functioning Scale-GFS, or any other validated scale)  
c) Quality of life (SF-36, World Health Organization Quality of Life Scale- WHOQOL, or 
any other validated scale)  
Outcomes would be grouped for analysis according to the duration of active treatment and 
follow up: less than 6 months, 6 to 12 months, 12 to 24 months. Thi  was not performed 
due to limited number of studies and heterogeneity of data.  
 
Search strategy for identification of studies 
1) Electronic search  
The following databases were searched to identify randomised or quasi-randomised 
controlled trials: The Cochrane Controlled Trials Register (2006-2), MEDLINE (1966-
2006) EMBASE (1980-2006), and LILACS (1982-2006). The "optimal" MEDLINE, 
EMBASE and LILACS sensitive search strategies for identification of controlled clinical 
trials (Castro 1997; Dickersin 1994) was combined with the following phrases:  
#1 ((bipolar disorder) OR (bipolar illness) OR (bipolar psychosis) OR (manic-depressive 
illness) OR (manic-depressive psychosis) OR (manic disorder) OR mania OR (manic 
psychosis) OR (hypomani*) OR (mixed state) OR (mixed episode) OR (bipolar depression) 
OR (cyclothymi*))  
#2 ((family therapy) OR (family intervention) OR (family treatment) OR (family 
psychotherapy) OR (family psychoanalysis)OR (family ps chodynamic therapy) OR 
(supportive family therapy) OR (family cognitive behavioral therapy) OR (systemic family 
therapy) OR (family interpersonal therapy) OR (family focused therapy) OR (family social 
rhythm therapy) OR (family psychoeducation*) OR (family psycho-education*) OR 
(couples therapy) OR (marital therapy) OR (spouses th rapy))  
2) References of the included studies  
3) Personal communication with the authors of included studies  
Methods of the review 
Selection of trials:  
LPJ and BGOS screened abstracts of all publications obtained by the search strategy (a 
track record was kept). The articles potentially suitable for the review were obtained in full 
to assess their relevance based on inclusion criteria (all potential RCTs in family therapies).  
Quality assessment:  
The quality of each trial was based on the criteria of quality specified by Shultz 1995, 
which measures a wider range of factors:  
1) Minimisation of selection bias: a) was the randomisation procedure adequate? b) was the 
allocation concealment adequate?  
2) Minimisation of attrition bias: a) were the withdrawals and dropouts completely 
described? b) was analysis by intention to treat?  
3) Minimisation of detection bias: a) were outcome assessors blind to the intervention?  
Based on these criteria, studies were classified according to the criteria described in the 
Cochrane Handbook (Higgins 2005):  
A-Low risk of bias (all quality criteria met)  
B-Moderate risk of bias (quality criteria partially met)  
C-High risk of bias (one or more criteria not met)  
Trials were assessed independently by two authors (LPJ, BGOS). In cases of disagreement 
the third author would be contacted, but there was no need in this version of the review.  
 
Data extraction:  
Data were extracted independently by authors (LPJ, BGOS) using a standard data 
extraction form (Higgins 2005). This includes data on: methods (generation of the 
allocation sequence, concealment of allocation, sample size estimation, length of follow-
up), participant characteristics (diagnostic procedur s, age, gender, ethnic origin, criteria 
used to classify recurrence, number of patients randomised, reasons for withdrawal from 
the trial), interventions, and outcomes (specified previously, any other assessed outcomes, 
other events, length of follow-up, reporting of outcomes quality).  
Analysis:  
Review Manager 4.2.8 developed by the Cochrane Collab ration was used to organise and 
analyse data. Interventions were only be grouped if clinically compatible, otherwise they 
were analysed individually. Data entrance of a 20% sample of studies were entered 
independently in RevMan.  
For dichotomous data, relative risks (RR) with 95% confidence intervals (CI) was 
estimated based on the fixed effects model (and on the random effects model when 
heterogeneity is present) and according to an intention-to-treat analysis. Authors assumed 
that people who dropped out had a negative outcome, except in case there are death 
outcomes. For all statistically significant results, number needed to treat (NNT) or number 
needed to harm (NNH) were calculated with 95% confidence intervals (CI).  
Continuous outcomes were analysed if the mean and st ard deviation of endpoint 
measures were presented in the original articles. For the meta-analysis of continuous 
outcomes, mean differences (MD) between groups wereestimated. Data on continuous 
outcomes are frequently skewed, the mean not being the centre of distribution. The 
statistics for meta-analysis are thought to be ableto cope with some skew, but were 
formulated for parametric data. To avoid this potential pitfall the following standards are 
applied to all data before inclusion: a) standard deviations and means are obtained from 
authors, and b) for data with finite limits, such as endpoint scale data, the standard 
deviation (SD), when multiplied by two, must be less than mean. Otherwise the mean is 
unlikely to be an appropriate measure of the centre of the distribution (Altman 1996). Only 
non skewed data are presented in this review,  
Heterogeneity was assessed by a chi-square test and it is assumed to be present when 
significance level is lower 0.10 (p<0.10). When significant heterogeneity is present, an 
attempt would be made to explain the differences based on the clinical characteristics of the 
included studies. Data of these trials would not be included in the meta-analysis. In order to 
describe the percentage of the variability in effect that occurs due to heterogeneity rather 
than to chance, an I-squared calculation was also applied (values greater than 50% was 
considered substantial heterogeneity).  
Publication bias: to assess potential publication bias data would be punched onto a funnel 
graph (trial effect versus trial size)  
Subgroup analysis  
The following subgroups were planned to be analysed separately:  
- Interventions directed to spouse vs. interventions f r other relatives  
 
- Individually based vs. family interventions  
- psycho-educative methods vs. other methods  
Sensitivity analysis  
Randomised vs. quasi-randomised controlled trials.  
Description of studies 
1 - Search:  
Electronic searches generated 1892 references. Eighteen references were considered 
potentially relevant and were obtained and scrutinised. Nine of them did no meet inclusion 
criteria and are mentioned in the table of excluded stu ies. Seven studies, one of them with 
3 references, have met inclusion criteria and they ar  described below and in the table of 
included studies.  
2 - Excluded Studies  
Overall studies were excluded because of design, as they were not randomised nor quasi-
randomised controlled trials.  
3 - Awaiting Assessment  
None.  
4 - Included Studies  
4.1 - Participants  
Total number of participants in included trials is 393, part of them, i.e. 84 participants in 
Reinares 2004 and van Gent 1991, were spouses or caregivers (generally relatives). All of 
them were adults with ages ranging from 18 to 62 years. More characteristics of the 
participants are described in the table of included stu ies.  
4.2 - Interventions  
Experimental interventions were basically psychoeducational treatments for patients with 
their families or for the families without the participation of the patient. One intervention, 
Problem Centered Systems Therapy for the Family, was not specifically psychoeducational 
in Miller 2004.  
Patients in experimental and control groups received pharmacological treatment all the 
time.  
4.2.1 Family Focused Therapy (FFT): Two studies (Miklowitz 2003, Rea 2003) have made 
use of FFT as experimental treatment. FFT was an adpt tion for bipolar patients 
(Miklowitz 1997) of a previous psycho intervention model created for schizophrenic 
patients (Falloon 1984), it is a type of education for patients and their families. FFT 
consists of three components: psychoeducation about bipolar disorder, communication 
enhancement training and problem-solving skills training. FFT was administered in 21 one-
hour session (12 weekly, 6 biweekly and 3 monthly) in 3 consecutive modules: 
psychoeducation (7 sessions), communication enhancement training (7-10 sessions) and 
problem-solving skills (4-5 sessions), administered in the 9 months period following an 
episode of bipolar illness. One of the studies (Rea 2003) has compared FFT with an 
 
individual intervention named individually focused patient treatment in which the goals 
were to educate the patient about the illness, conduct crisis interventions and reduce 
ongoing life stress. The other has used as control a less intensive psychoeducational family 
intervention named crisis management (CM): two 1-hour home-based sessions of family 
psychoeducation within the first 2 months after study entry and crisis intervention sessions 
as needed during the remaining 9-month treatment period.  
4.2.2 Problem Centered Systems Therapy of the Family: It s a short-term, problem-
focused, semi-structured family intervention that includes a manual, based upon the 
McMaster Model of the family functioning (Epstein 1990). The therapy focus is directed to 
clinically relevant dimensions of family functioning as problem solving, communication, 
roles, affective responsiveness, affective involvement and behavior control. This therapy 
relies on a core set of therapeutic principles tailored to the individual family's problems. 
The specific problems of the family are determined by the therapist and the family together. 
The therapy is performed through a progressive serie  of stages: assessment, contracting, 
treatment and termination. The number of sessions varies depending on the needs of the 
family ranging from 6 to 10 fifty-minutes sessions. This intervention was studied in Miller 
2004 in a comparison with two other groups of treatment tha  were multifamily 
psychoeducation and pharmacotherapy alone.  
4.2.3 Multifamily Psychoeducational Group Therapy: This is a manual based semi-
structured intervention developed for the study Miller 2004 which included 4 to 6 patients 
and their family members above the age of 12. The sessions provided information about the 
bipolar disorder and taught members different coping strategies for common problems. The 
psychotherapists encouraged patients and family members to share their perspectives on 
family interactions. It was made in weekly 90-minutes 6 sessions, each of them focusing on 
a specific topic.  
4.2.4 Couple Psychoeducational Intervention: This wa a manual based psychoeducational 
intervention for patients and their partners, administered by social workers trained in family 
therapy. Couples in the experimental group have reciv d 25 (10 weekly and 15 bimonthly) 
sessions. In Clarkin 1998 this intervention was compared to standard medication for patient 
only.  
4.2.5 The psychoeducational family intervention studied in Reinares 2004 consisted of 12 
ninety-minutes group sessions for patients' caregivers, that took place at hospital. Relatives 
of 10 mood stabilized patients were included in each group and the patients themselves did 
to attend the group sessions. Oral information about the illness and guidelines on its 
management were provided. Encouraging discussion between participants was facilitated. 
After each session the participants have received a written summary about the topic of the 
day. The same psychologist has conducted all the groups. In the control group patients have 
received pharmacological treatment in the same algorithms of the Barcelona Bipolar 
Disorders Program that were administered to patients of experimental group and the 
patients' relatives did not receive psychoeducationl intervention. In a similar way the study 
of van Gent 1991 only patients' partners have received a psychoeducational intervention. 
The partners have attended 5 sessions in which information about the illness, 
pharmacological treatment and practical advice was provided also in this study written 
 
material was given to participants. Partners' experiences were solicited and discussed in the 
sessions. The group sessions were conducted by a psychiatrist and a social worker.  
4.2.6 Inpatient Family Intervention: this type of intervention was used in Clarkin 1990. It 
was designed for inpatients and their families to be performed during the period the patient 
were in the hospital through at least six 45 min-1 hour family intervention sessions. It is a 
manual based psychoeducational method whose goals were acceptance and understanding 
by the patient and family of the reality of the illness, identification of precipitating stresses 
for present episode and future, within and outside of the family, elucidation of family 
interactions, planning strategies for managing stres es and acceptance of the need for 
continued treatment after discharge.  
4.3 - Outcomes  
4.3.1 Dropouts (after randomisation): data were report d in all of them.  
4.3.2 Patients' affective symptoms: measured by standard rating scales as Hamilton 
Depression Rating Scale, Young Mania Rating Scale, Schedule for Affective Disorders and 
Schizophrenia-Change version, Brief Psychiatric Rating Scale, Bech-Rafaelsen Mania 
Scale.  
4.3.3 Recovery (numbers of patients that have reached it in the comparison groups): using 
rates of symptoms scales and transforming it in dichotomous measures (yes or not).  
4.3.4 Hospitalizations or rehospitalizations.  
4.3.5 Adherence to pharmacologic treatment measured th ough scales in which could be 
included data provided by patients and their family or by laboratory tests.  
4.3.6 Relationship within the family measured through Family Environment Scale.  
4.4 - Settings  
Two of the included studies were performed in Europe, one in Spain (Reinares 2004) and 
another in Netherlands ( van Gent 1991). Remaining included studies were conducted in 
USA.  
Methodological quality of included studies 
• Allocation  
All studies included in this review are described as r ndomised by their authors, 
nevertheless only three of them (Reinares 2004, Miklowitz 2003, Clarkin 1998) provided 
some specific information regarding randomisation processes. Only one study has 
mentioned allocation concealment (Miklowitz 2003) with randomisation sequence 
concealed until assignements had been made.  
• Blindness to Evaluation of Outcomes  
 
Four of the included studies have reported blindness for outcome measurements (Reinares 
2004, Miklowitz 2003, Rea 2003, Clarkin 1990); one of them (Miklowitz 2003) provided 
secondary blinded evaluators to analyse information through video-tapes of interviews and 
the authors have compared the primary and secondary outcomes rates because they 
considered very difficult to keep the patients' psychosocial group assignments; the others 
(Reinares 2004, Rea 2003, Clarkin 1990) has simply utilized evaluators blinded to the type 
of patients' psychosocial treatment group.  
• Intention-To-Treat Analysis and Loss to Follow Up  
Intention-to-treat analysis were performed in 2 studies (Miller 2004, Rea 2003) in what all 
participants randomised were included in final analysis. One study (Miklowitz 2003) did 
not included the early terminators patients in final st tistical analysis but provided data of 
them. Another trial (Reinares 2004) has mentioned the loss of two participants because they 
failed to complete endpoint assessments but did not inform wether they were or were not 
included in final data. In another study (van Gent 1991) 5 of the 19 participants randomised 
to the experimental group and 8 of the 20 participants randomised to the control group were 
not allowed to be enrolled in the study by the patients (their partners) and they were 
considered dropouts. One study has reported missing data and there is a mention to 
intention-to-treat analysis procedure related to comp site outcomes but not for individual 
measures (Clarkin 1990). With just one exception (Clarkin 1998) in all reported studies 
there explanations about reasons for dropouts.  
Results 
1. Comparisons:  
1.1. Family intervention VS. no psychosocial intervention  
We have found 5 studies comparing any type of psychosocial intervention in family 
(partners, caregivers or other members of family) (Miller 2004, Reinares 2004, Clarkin 
1998, van Gent 1991, Clarkin 1990, ) to no family psychosocial intervention. Regarding 
outcomes it was possible to use dropouts rates of all studies. Other available outcomes were 
clinical improvement (van Gent 1991, Clarkin 1990), medication compliance (van Gent 
1991), recovery (Miller 2004), and relationships in the family environment - 
expressiveness, cohesion, conflict - (Reinares 2004).  
In van Gent 1991 no patients were hospitalized during the study. However in this same 
study, patientes presented an increased level of anxiety with the family intervention when 
compared to no psychossocial intervention group (WMD 0.69; 95% CI 0.05-1.34). Except 
for this result, there were no significant differenc s between groups of comparison for all 
other outcomes considered in this group of interventions.  
1.2. Family intervention VS. individual intervention  
Only one study have been found comparing a family psychosocial intervention to an 
individual psychosocial intervention (Rea 2003). Both interventions were based on similar 
principles and the main difference was the administration to the patient alone or with his 
family. The outcomes used were relapse, rehospitaliza ion, medication compliance and 
dropouts without significant differences between groups.  
 
1.3. Family intervention VS. family intervention  
There are 2 studies preforming comparisons between 2 types of family psychosocial 
interventions (Miller 2004, Miklowitz 2003). One of them compares a specific family 
intervention called Problem Centered Systems Therapy of the Family to a multifamily 
group of psychoeducation intervention (Miller 2004). The other one compares a specific 
intervention named Family-Focused Therapy to a more simple intervention called Crisis 
Management that was administered to family too, but in a less intensive and complex way 
(Miklowitz 2003). The outcomes used were relapse (Miklowitz 2003), recovery (Miller 
2004), medication compliance (Miklowitz 2003) and dropouts (Miller 2004, Miklowitz 
2003). No differences were detected for these outcomes in all comparisons.  
For relapse prevention, family focused therapy was significantly superior to crisis 
management in preventing relapse (RR =0.59 95% CI 0.39- .88; NNT=3.1; CI 1.9-8.3).  
 
1.4 Family intervention VS. no psychosocial intervention: retention in treatment  
One meta-analysis of dropout rates with 214 subjects in 5 studies did not show any relevant 
difference between family interventions versus no intervention (RR=0.70 95%CI 0.43-
1.14).  
2. Other data  
2.1 Survival analysis  
Data from survival analysis can not be re-analysed in Review Manager, but two studies 
presented very relevant data (primary outcomes) in this way. Miklowitz 2003 has 
demonstrated superiority in results of Family Focused Therarapy group over the Crisis 
Management group for time to relapse (Wilcoxon x2 = 8.71, p = 0.03) and Miller 2004 has 
showed the survival analysis for time to recovery wthitout any significant statisc difference 
between the three groups of comparison (log rank x2 = 1.21, df = 2, p = 0.55).  
2.2 ANOVA  
Miklowitz 2003 reported results of a repeated-mesure mixed-model ANOVA regarding 
effect of time on total affective symptoms scores (measured by SADS-C). There was a 
statistically significant treatment group VS. time interaction (F7,549=2.81, p=0.007) for 
symptom severity stabilized at lower level, which means that the FFT group presented 
significant lower/ better scores from 6 months of trea ment. These data could not be re-
analysed to be presented in a graphical form in this review.  
Discussion 
In general, there is an increased acceptance of the need of adjuvant psychosocial 
interventions (psychotherapy and psychoeducational methods) added to standard 
medications, regarding the treatment of bipolar disor ers. The addition of psychosocial 
intervention is supposed to reduce symptoms, enhance so ial functioning, reduce 
hospitalizations and relapses rates and increase treatment adherence (Vieta 2005 b; 
Gutierrez 2004). Results of a systematic review of the literature (Vi ta 2005 a) about 
general psychological interventions for bipolar disorder has found evidences of benefits in 
combination of pharmacologic treatment with them. Furthermore, the same study brings up 
a noteworthy point that is the possible differences of impact on the treatment of different 
 
bipolar patients. Also, mood fluctuations may have multiple distinct aspects in different 
patients and it possibly demands developments in psychologic interventions models in 
order to manage the complexity of the illness (Jones 2005). Some authors working in this 
field recommend the implementation of family intervntions for the treatment of bipolar 
disorders (Miklowitz 2006). Among the psychosocial interventions, family interventions 
are considered promising ways to improve therapeutic resources. Nevertheless, the studies 
with appropriate methods to produce good quality evidence are more the exception than the 
rule in the literature. Only seven RCTs in family psychosocial interventions for bipolar 
disorder have been found. All of them were trials about psychoeducational methods, and 
only one has assessed a specific type of psychotherapy (Problem Centered Systems 
Therapy of the Family) as one of the three arms of the study (Miller 2004). These studies 
presented descriptions of samples' characteristics at baseline, diagnostic procedures, and 
inclusion/exclusion criteria, they used relevant outc mes, and presented detailed 
descriptions of interventions. However, outcomes were diversified and, many times, 
measured in a way that prevented their inclusion in our analysis, as those trials that have 
used survival analysis (Miller 2004; Miklowitz 2003; Rea 2003). Some outcomes were not 
direct clinical outcomes and were not presented, such as knowledge about the disease 
(Reinares 2004; van Gent 1991). Results of this review are limited due to the heterogeneity 
of studies specially because they assessed different outcomes and the number of trials for 
each type of comparison performed were small and often one and only.  
Miklowitz 2003, a 2 years trial, presented a clinically relevant result: in each 3 patients 
treated with family focused therapy 1 less would reapse in this time course, in comparison 
to a crisis management intervention. Other interesting result, with clinical and statistical 
significance, came from van Gent 1991, where subjects submitted to marital 
psychoeducation had a worse mean score in the anxiety scale (WMD 0.69; 95%CI 0.05-
1.34). This could be considered a side-effet and maybe the intervention caused discomfort 
induced by the knowledge of the dificult aspects of the disorder as chronicity and that 
patients can relapse even with adequate medication.  
It would be useful to produce more trials aiming detection of possible placebo effect 
generated by contact with health professionals even without specific intervention in control 
groups.  
 
An important aspect is that, although it was not possible to find many significant results 
favouring psychosocial interventions, it is not reasonable to conclude that family 
psychosocial interventions added to pharmacological tre tment of bipolar disorders are 
definitively not useful. It is possible that family nterventions can be an important resource 
to help patients, relatives and clinicians in the task of better dealing with the illness and its 
consequences. What is clear with this review is that i  is difficult a precise evaluation of 
psychosocial interventions' effectiveness, mainly due to the randomised controlled trials' 
limitations themselves. It is highly desirable that professionals working in this field become 
concerned in carrying out well designed studies.  
 
Reviewers' conclusions 
Implications for practice 
The addition of family psychotherapy or psychoeducation l methods to medications (and 
other interventions) to treat bipolar patients may be a good practice, but it is necessary to 
wait for better evidences allowing more clear conclusions. Until now the amount of good 
quality data is very poor and it prevents recommendation of family interventions to health 
policy makers. Considering costs/benefits relation is a worthwhile concern regarding 
economic aspects plus patients and family affective in stments and expectations.  
Implications for research 
Researchers should pay attention to the need of adequ t  scientific data to show the 
efficacy and effectiveness of family psychosocial interventions in the treatment of bipolar 
disorders. Randomised controlled trials following rigid methods of randomisation, outome 
assessments, and precise reports are still missing in this topic  
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BPRS: Brief Psychiatry Rating Scale 
DSM-III: Diagnostic and Statistical Manual of Mental Disorders - Third Edition 
DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders - Third Edition Revised 
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition 
N: total number of participants in the study 
n: number of participants in a group of comparison 
SADS-C: Schedule for Affective Disorders and Schizophrenia - Change Version 
SCID: Structured Clinical Interview (DSM) 
SCID-P: Structured Clinical Interview- Patient Version 
SCL: Symptom Checklist 
SD: Standard Deviation 
Characteristics of excluded studies 
Study Reason for exclusion 
Anderson 
1986 
The outcomes assessed were not clinical outcomes dir ctly related to the 
bipolar disorder. It was not exposed data about the impact of the interventions 
on the illness itself.  
Catanzaro 
1973 




The study was not a RCT. 
Fitzgerald 
1972 
The study was not a RCT. 
Fristad 
2002 
The outcomes considered in this study were not directly clinical , although, 
they possibly may be related to some clinical outcomes in an indirect way. It 
was not showed data about the possible impact on patients' status of the 
disorder related to the intervention. 
 
Honig 1995 The study was not a RCT. 
Kim 2004 This was not an primary RCT. Data were collected from two others studies, 
one of them included in the present review (Miklowitz 2003). 
Miklowitz 
2000 
The study reported is the same of Miklowitz 2003, in one year of follow up 
(the data is a parcial result of the study included in this review). 
Simoneau 
1999 
The study reported in this paper is presentation of the partial results of the 
study reported in Miklowitz, 2003, included in this review. 
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Comparisons and data 
01 Family-Focused Therapy VS. Individually-Focused Therapy 
01.01 Relapse rates 
01.01.01 at the end of treatment (12 months) 
Study ID Family T n Family T N Individual T n  Individual T N  
Rea 2003 13 28 13 25 
01.02 Rehospitalization 
01.02.01 at the end of treatment (12 months) 
Study ID Family T n Family T N Individual T n  Individual T N  
Rea 2003 8 28 10 25 
01.03 Medication compliance (high score is better) 




















13 4.13 2.70 16 3.90 2.66 
01.04 Dropouts 
01.04.01 at the end of the study - 24 months 
Study ID Family T n Family T N Individual T n  Individual T N  
Rea 2003 12 28 12 25 
02 Family Therapy Vs. Multifamily Psychoeducation Group Therapy 
02.01 No recovery for all patients 
02.01.01 at the end of study (28 months) 
Study ID Family T n Family T N Multifamily Psycoed n Multifamily Psycoed N 
 
Miller 2004 17 33 9 30 
02.02 No recovery for patients with mania 
02.02.01 at the end of study (28 months) 
Study ID Family T n Family T N Multifamily Psychoed n Multifamily Psychoed N 
Miller 2004 6 23 12 24 
02.03 Dropouts 
02.03.01 at month 6 










12 33 10 33 
03 Family Therapy VS. No Family Therapy 
03.01 No recovery for all patients 
03.01.01 at the end of study (28 months) 
Study ID No Family Therapy n 








13 29 17 33 
03.02 No recovery for patients with mania 
03.02.01 at the end of study (28 months) 
Study ID No Family 
Therapy n 








9 22 12 24 
03.03 Dropouts 
03.03.01 at month 6 
 










12 33 10 29 
03.03.02 before month 6 










3 15 2 11 
03.04 No significant clinical improvement 
03.04.01 at discharge 









2 15 3 11 
03.04.02 at month 6 









1 15 1 11 
04 Multifamily Psychoeducation Group Therapy VS No Multifamily Psychoeducation 
Group Therapy 
04.01 No recovery for all patients 
04.01.01 at the end of study (28 months) 









13 29 9 30 
04.02 No recovery for patients with mania 
 
04.02.01 at the end of study (28 months) 










9 22 6 23 
04.03 Dropouts 













10 30 10 29 
05 Psychoeducation for Caregivers VS. No Psychoeducation for Caregivers 












































15 5.71 1.54 30 5.76 2.06 























30 2.41 1.52 15 2.93 1.59 
05.03 Dropouts 





for ca n 
No Psychoeduc 
for ca N 
Reinares 
2004 
1 15 1 30 
06 Family-Focused Therapy VS Crisis Management (for family) 
06.01 Relapse 
06.01.01 at the end of study (24 months) 









14 31 54 70 
06.02 Medication compliance (high is better) 
























43 2.56 0.48 22 2.77 0.43 
06.03 Dropouts 
06.03.01 before 6 months 










3 31 16 70 
06.03.02 at the end of study (24 months) 









9 31 27 70 
07 Marital Psychoeducation (for partners) VS. No Marital Psychoeducation 
07.01 Dropouts 
07.01.02 at end of study (12 months) 









5 19 8 20 
07.02 No medication compliance 
07.02.02 at end of study (12 months) 









10 12 11 14 
























19 43.40 13.50 20 35.10 9.70 
07.04 Patients' Total Symptoms Ater Sudy (SCL-90) (low is better) 
Study Marital Marital Marital No No No 
 















19 121.40 31.70 20 120.40 24.10 
























19 13.50 5.00 20 13.00 4.00 
08 Couples Psychoeducation (patient + partner) VS. No couples Psychoeducation 
08.01 Dropouts 









1 19 8 23 
09 Family Psychosocial Intervention VS. No Psychosocial Intervention 
09.01 Dropouts 
09.01.01 at 11 months 
Study ID Family Therapy n Family Therapy N No Psyc Int n No Psyc Int N 
Clarkin 1998 1 19 8 23 
09.01.02 at 12 months 
Study ID Family Therapy n Family Therapy N No Psyc Int n No Psyc Int N 
van Gent 1991 5 19 8 20 
09.01.03 at 28 months 
Study ID Family Therapy n Family Therapy N No Psyc Int n No Psyc Int N 
 
Miller 2004 12 33 10 29 
09.01.04 at 6 months 
Study ID Family Therapy n Family Therapy N No Psyc Int n No Psyc Int N 
Reinares 2004 1 30 1 15 
09.01.05 at 18 months 
Study ID Family Therapy n Family Therapy N No Psyc Int n No Psyc Int N 
Clarkin 1990 3 15 2 11 
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